Drawing for HMNC BRAIN HEALTH

USPTO serial 79337706

HMNC BRAIN HEALTH

Reviewed by CopyMark Law Group

Reg. 7102448Status 700Registered
Filing date
Status date
Registration date
Jul 11, 2023
Examiner
STEEL, ALYSSA PALADINO
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HMNC BRAIN HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret C. McHugh

Margaret C. McHugh Kilpatrick Townsend & Stockton, LLPTwo Embarcadero Center, Suite 1900San Francisco, CA 94111UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical test kits for testing gene samples to identify individuals at risk of developing mental health disorders, for laboratory or research use; chemical diagnostic reagents for industrial use; chemical preparations for scientific diagnostic purposes; diagnostic preparations for scientific or research useACTIVE—
005Pharmaceutical products for the treatment of mental health; medical preparations for the treatment of mental health; medical diagnostic test strips for use in the field of mental health; preparations for the detection of genetic predispositions for medical purposes; reagents for use in medical genetic testing; diagnostic agents and materials, being preparations and substances, for medical purposes; diagnostic test materials, being test media in the form of strips for measuring mental health conditions and disorders for medical useACTIVE—
009Scientific research and laboratory apparatus, for use in analyzing genetic information and screening mental health conditions and disorders; laboratory equipment and instruments, for use in analyzing genetic information and screening mental health conditions and disorders; laboratory equipment for analyzing genetic information, for use in screening mental health conditions and disordersACTIVE—
010Apparatus for DNA and RNA testing for medical purposes; genetic testing apparatus for medical purposes; medical diagnostic apparatus for biomarker testingACTIVE—
042Scientific and technological services, namely, research in the field of mental health; DNA screening for scientific research purposes; providing scientific advice on gene therapy research; scientific research in the field of genetics; scientific research in the field of gene therapy; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific research in the field of genetics; analytical scientific laboratory services; medical laboratory services; performance of laboratory analysis in the field of biomarker testing; conducting laboratory tests in the field of biomarker testing for scientific purposes; laboratory services for analytical tests, namely, biomarker testing for scientific purposes; scientific laboratory services; laboratory research in the field of biomarkers; study of materials in laboratories, namely, scientific research in the field of biomarkers; conducting laboratory tests and laboratory analysis in the field of biomarkers; scientific research and development; development of pharmaceutical preparations and medicines; scientific research and development services in the field of diagnostic agents; scientific research and development services for the pharmaceutical industry; design of scientific diagnostic instruments and devicesACTIVE—
044Medical services; medical diagnostic services, namely, testing and analysis for the presence of mental health conditions and disorders; medical analysis for the diagnosis and treatment of humans; DNA screening for medical purposes; genetic testing for medical purposes; performing genetic tests for medical diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; medical and healthcare services relating to DNA, genetics and genetic testing, namely, mental health services; genetic counseling; medical analysis services of samples from patients for diagnostic and treatment purposes provided by medical laboratories; conducting clinical laboratory tests for diagnostic or treatment purposes, being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; psychiatric therapy services; provision of personalized health care and medical information in the nature of mental health; providing information and advice relating to medical and health care servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 12, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 12, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 11, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 20, 2023DMCCDATA MODIFICATION COMPLETED—
Mar 20, 2023ALIEASSIGNED TO LIE—
Mar 17, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 16, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2022RFNTREFUSAL PROCESSED BY IB—
Sep 19, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 19, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 23, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2022DOCKASSIGNED TO EXAMINER—
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance